Trial Profile
Pharmacodynamics and pharmacokinetics of tolvaptan in fasting and fed male Japanese and Causcasian volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jul 2012
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure; Hypertension
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 27 Jul 2012 New trial record